These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 13141543)

  • 1. [Irreversibility of the action of erythromycin and magnamycin on Staphylococcus pyogenes Oxford].
    LECOCQ E
    C R Seances Soc Biol Fil; 1953; 147(15-18):1484-6. PubMed ID: 13141543
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evolution of the types of resistance of pathogenic staphylococcus to antibiotics common in 1950 to 1953; action of bacitracin, erythromycin, magnamycin and soframycin in vitro].
    LUTZ A; GROOTTEN O; WITZ A
    Strasb Med; 1954 Jan; 5(1):9-26. PubMed ID: 13156849
    [No Abstract]   [Full Text] [Related]  

  • 3. [Properties of erythromycin and magnamycin].
    LECOCQ E
    C R Seances Soc Biol Fil; 1953; 147(15-18):1480-4. PubMed ID: 13141542
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of cross resistance to erythromycin and carbomycin in Micrococcus pyogenes var. aureus.
    HSIE JY; KOTZ R; NUSSER W
    Antibiot Annu; 1955-1956; 3():773-7. PubMed ID: 13355361
    [No Abstract]   [Full Text] [Related]  

  • 5. Induced resistance of staphylococci to carbomycin and erythromycin.
    RAJAM PC; ADCOCK JD
    Med Bull (Ann Arbor); 1953 Aug; 19(8):212-7. PubMed ID: 13090461
    [No Abstract]   [Full Text] [Related]  

  • 6. [Development and modifications of the resistance of pathogenic staphylococci to six common antibiotics from 1950 to 1956; comparative action in vitro of erythromycin, magnamycin, spiramycin, novobiocin (albamycin) and oleandomycin].
    LUTZ A; GROOTTEN O; HOFFERER MJ
    Ann Inst Pasteur (Paris); 1957 Jun; 92(6):778-89. PubMed ID: 13444794
    [No Abstract]   [Full Text] [Related]  

  • 7. [Crossed resistance of staphylococci to erythromycin and carbomycin after exposure to each of the two antibiotics].
    SCURO LA; ORTONA L
    Boll Soc Ital Biol Sper; 1953; 29(9-10-11):1739-41. PubMed ID: 13140697
    [No Abstract]   [Full Text] [Related]  

  • 8. [Technical considerations on the determination of magnamycin].
    DONY J
    Ann Pharm Fr; 1954 Apr; 12(4):307-13. PubMed ID: 13189204
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro action of spiramycin on 153 strains of Staphylococcus pyogenes & its comparison with penicillin & erythromycin].
    ACOCELLA M; BARTOLOZZI G; PANERO C
    G Ital Chemioter; 1957; 4(3-4):470-7. PubMed ID: 13562590
    [No Abstract]   [Full Text] [Related]  

  • 10. Oleandomycin: cross-resistance studies with clinical isolates of Micrococcus pyogenes var. aureus.
    ENGLISH AR
    Antibiot Annu; 1957-1958; 5():756-9. PubMed ID: 13521891
    [No Abstract]   [Full Text] [Related]  

  • 11. [In vitro effect of spiramycin on 153 strains of Staphylococcus pyogenes; comparison with the effect of penicillin & erythromycin].
    BARTOLOZZI G; ACOCELLA M; PANERO C
    Riv Clin Pediatr; 1957 Apr; 59(4):339-51. PubMed ID: 13466831
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the sensitivity of various strains of Staphylococcus to erythromycin: determination of the mutation rate to erythromycin resistance].
    DOBRZANSKI WT; EYSYMONTT I
    Med Dosw Mikrobiol; 1958; 10(1):127-39. PubMed ID: 13551892
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of association of penicillin and erythromycin on strains of pathogenic and penicillin resistant staphylococcus].
    ORTONA L; SORICE F
    Boll Ist Sieroter Milan; 1953; 32(11-12):489-95. PubMed ID: 13140471
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in sensitivity of Micrococcus pyogenes to erythromycin over a period of 2 years.
    MARTIN WJ; NICHOLS DR; WELLMAN WE; GERACI JE
    Proc Staff Meet Mayo Clin; 1954 Jun; 29(13):379-87. PubMed ID: 13177707
    [No Abstract]   [Full Text] [Related]  

  • 15. The pattern of the development of resistance and dependence to carbomycin in Micrococcus pyogenes var. aureus.
    HSIE JY; KOTZ R
    Antibiot Chemother (Northfield); 1955 Dec; 5(12):744-51. PubMed ID: 24543814
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythromycin sensitivity of Micrococcus pyogenes var. aureus in a hospital population (development of resistance).
    GRIGSBY ME; CHAPPELLE E; PEACOCK T
    Antibiot Chemother (Northfield); 1955 Jun; 5(6):350-2. PubMed ID: 24543667
    [No Abstract]   [Full Text] [Related]  

  • 17. The epidemiology of an erythromycin resistant Staphylococcus.
    MACCABE AF; GOULD JC
    Scott Med J; 1956 Jul; 1(7):223-6. PubMed ID: 13351658
    [No Abstract]   [Full Text] [Related]  

  • 18. [Increased resistance of staphylococci to erythromycin].
    JUEL E
    Tidsskr Nor Laegeforen; 1956 Sep; 76(18):655-6. PubMed ID: 13380829
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of sensitivity of erythromycin and of erythromycin combined with other antibiotics].
    DE CARLI L
    Boll Ist Sieroter Milan; 1954; 33(11-12):554-67. PubMed ID: 14363403
    [No Abstract]   [Full Text] [Related]  

  • 20. [In vitro action of novobiocin on 153 strains of Staphylococcus pyogenes].
    ACOCELLA M; GIUSTI M; MORI S; SANGIORGI A
    G Ital Chemioter; 1957; 4(3-4):530-8. PubMed ID: 13562601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.